Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis. [PDF]
Haruma K +9 more
europepmc +1 more source
Utility of the 13 C-pantoprazole breath test as a CYP2C19 phenotyping probe for children. [PDF]
Feldman K +9 more
europepmc +1 more source
Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency. [PDF]
Mannemuddhu SS +5 more
europepmc +1 more source
Identification of the New In Vivo Metabolites of Ilaprazole in Rat Plasma after Oral Administration by LC-MS: In Silico Prediction of the H+/K+-ATPase Inhibitor. [PDF]
Zhang G, Guo K, Wang P, Shan Y, Ma C.
europepmc +1 more source
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>. [PDF]
Jeffreys LN +20 more
europepmc +1 more source
Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients. [PDF]
Zhao YC +9 more
europepmc +1 more source
Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use. [PDF]
Chen F, He X, Fang B, Wang S.
europepmc +1 more source
The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori. [PDF]
Lee SW +7 more
europepmc +1 more source
Cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusion. [PDF]
Santos ACD +10 more
europepmc +1 more source
14-day Empirical Therapy Compared with 7-day Tailored Therapy for <i>Helicobacter pylori</i> Eradication in Korea: Results of the K-CREATE Phase II Study. [PDF]
Kim JS +10 more
europepmc +1 more source

